Evidence map›Paper›PMID 28600641›Full record

ArticleJournal of digital imaging2017

Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence.

Zeynettin Akkus, Issa Ali, Jiří Sedlář, Jay P Agrawal, Ian F Parney, Caterina Giannini, Bradley J Erickson

Abstract read
In one paragraph

Article in Journal of digital imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. OMT and tensor SVD-based deep learning model for segmentation and predicting genetic markers of glioma: A multicenter study.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Machine Learning and Radiomics in Gliomas.Advances in experimental medicine and biology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Deep learning in precision medicine and focus on glioma.Bioengineering & translational medicine · 2023
    Review
  18. Review
  19. Review
  20. Artificial intelligence in neuro-oncology.Frontiers in neuroscience · 2023
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zeynettin AkkusRadiology Informatics Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Issa AliRadiology Informatics Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Jiří SedlářRadiology Informatics Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Jay P AgrawalRadiology Informatics Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Ian F ParneyDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
Caterina GianniniDepartment of Pathology, Mayo Clinic, Rochester, MN, USA.
Bradley J EricksonRadiology Informatics Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. bje@mayo.edu.

Funding

Objective decision support environment for clinical trialsU01CA160045 · NCI · MAYO CLINIC ROCHESTER · PI ERICKSON, BRADLEY J. · 2012 to 2016
$2.6M
NCI NIH HHS U01 CA160045
6 · The paper itself

Abstract

Several studies have linked codeletion of chromosome arms 1p/19q in low-grade gliomas (LGG) with positive response to treatment and longer progression-free survival. Hence, predicting 1p/19q status is crucial for effective treatment planning of LGG. In this study, we predict the 1p/19q status from MR images using convolutional neural networks (CNN), which could be a non-invasive alternative to surgical biopsy and histopathological analysis. Our method consists of three main steps: image registration, tumor segmentation, and classification of 1p/19q status using CNN. We included a total of 159 LGG with 3 image slices each who had biopsy-proven 1p/19q status (57 non-deleted and 102 codeleted) and preoperative postcontrast-T1 (T1C) and T2 images. We divided our data into training, validation, and test sets. The training data was balanced for equal class probability and was then augmented with iterations of random translational shift, rotation, and horizontal and vertical flips to increase the size of the training set. We shuffled and augmented the training data to counter overfitting in each epoch. Finally, we evaluated several configurations of a multi-scale CNN architecture until training and validation accuracies became consistent. The results of the best performing configuration on the unseen test set were 93.3% (sensitivity), 82.22% (specificity), and 87.7% (accuracy). Multi-scale CNN with their self-learning capability provides promising results for predicting 1p/19q status non-invasively based on T1C and T2 images. Predicting 1p/19q status non-invasively from MR images would allow selecting effective treatment strategies for LGG patients without the need for surgical biopsy.

Indexed as

Artificial IntelligenceChromosome DeletionChromosomes, Human, Pair 1Chromosomes, Human, Pair 19Brain NeoplasmsGliomaHumansMachine Learning1p/19q codeletionConvolutional neural networksLow grade gliomasTherapy response

Identifiers

PMID28600641
PMCPMC5537096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.